Yüklüyor......
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis
BACKGROUND: Methotrexate is considered the preferred disease‐modifying anti‐rheumatic drug (DMARD) for the treatment of rheumatoid arthritis, but controversy exists on the additional benefits and harms of combining methotrexate with other DMARDs. OBJECTIVES: To compare methotrexate and methotrexate‐...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2016
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7087436/ https://ncbi.nlm.nih.gov/pubmed/27571502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010227.pub2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|